Anti-vertigo drug prescribing for patients with vestibular symptoms in primary care: a retrospective observational cohort study

Hà TN Ngo, Otto R Maarsingh, Pauline Slottje, Marco H Blanker, Feikje Groenhof, Jettie Bont, Vincent A van Vugt · 2025

Read Anti-vertigo drug prescribing for patients with vestibular symptoms in primary care: a retrospective observational cohort study by Hà TN Ngo, Otto R Maarsingh, Pauline Slottje, Marco H Blanker, Feikje Groenhof, Jettie Bont, Vincent A van Vugt (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12820506.txt.

Description

Ha Ngo and co-authors examine how often family doctors prescribe anti-vertigo drugs, and for how long, in this 2025 study. Evidence that these drugs help dizziness is thin. One of them, betahistine, is still among the most prescribed off-label drugs. Doctors in primary care likely write much of that volume. The team mined records from hundreds of Dutch practices. More than a million patients' data covered the years 2018 to 2021.

They counted new and long-term prescriptions for patients with balance symptoms. Traits linked to long-term use were also sought. Long courses are the worry when benefit is unproven. The study is records-based, with identities removed. Its findings can feed prescribing guidance and review campaigns. Dizzy patients are common in primary care, so even small rates mean many people.

Catalog record

CREATORHà TN Ngo, Otto R Maarsingh, Pauline Slottje, Marco H Blanker, Feikje Groenhof, Jettie Bont, Vincent A van Vugt
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE30 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12820506

Browse the full library · About the Tower of Babel